DHA Supplements Market Analysis & Forecast: 2026-2033
The DHA supplements market is estimated to be valued at USD 1,943 Mn in 2026 and expected to reach USD 3,139 Mn by 2033, witnessing a CAGR of 7.0% over the forecast period (2026-2033).
Docosahexaenoic acid (DHA) is one of the most essential omega-3 fatty acids. It is linked to the benefits such as improved heart health, better vision, and reduced inflammatory response. DHA is found in every cell of the body and plays a critical role in brain development during pregnancy and infancy. DHA is essential for the health of the skin, eyes, and brain. Because the body cannot produce enough DHA that is required, it must be obtained through diet.
|
Current Event |
Description and its Impact |
|
Regulatory Changes in Key Markets |
|
|
Technological Innovations and Manufacturing Developments |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
In terms of sources, the fish oil segment is projected to capture 58% share of the market in 2026, due to its good reputation, wide availability, and cost-effectiveness. People trust fish-derived omega-3 for cardiovascular and brain health benefits. Fish oil is still the most popular oil, even though there are sustainability concerns. However, algal oil is quickly becoming popular with vegans and eco-conscious buyers.
For instance, in February 2026, GC Rieber Vivomega added vegan DHA and EPA algal oil to its line of omega-3 products. This new product is a plant-based, long-lasting alternative to fish oil that is aimed at health-conscious people, especially vegetarians and vegans. It also has omega-3 fatty acids that are good for the brain, heart, and eyes.
In terms of form, the capsules segment is projected to account for 67% share of the market in 2026, because they are easy to use, have a long shelf life, and precise dosage. Capsules are the simplest form for people to use every day. Capsule-based DHA formulations are extremely popular with people of all ages, and pharmaceutical companies and supplement brands around the world heavily promote them.
For instance, in January 2026, Zpeer Inc., a Japanese company, made A-DHA-PT, a DHA supplement for dogs in high concentration. The goal was to help keep their brains healthy. They will work with the University of Tokyo to study how DHA might help reduce the number of seizures in dogs with epilepsy. This shows how DHA is becoming more important in veterinary health and nutrition.
In terms of application, the dietary supplements segment is expected to lead the market with 59.1% share in 2026, owing to more people being aware of their health and the trend toward preventive healthcare. A greater number of individuals are taking DHA capsules and soft gels to support their brains, eyes, and hearts health. Strong marketing, easy access, and more people in their 40s and 50s using it are all good things for this group.
For instance, in February 2026, Researchers at the University of Michigan found that the cancer-fighting benefits of omega-3 fish oil depend on the enzyme ALOX15. When ALOX15 was active, EPA reduced colorectal tumors from growing when ALOX15 was active, DHA sometimes made tumors grow faster. The study shows that genetics and the form of the supplement are two important factors that affect how well omega-3 works to prevent cancer.
In terms of distribution Channel, the pharmacy & drug stores segment is expected to hold 42.7% share of the market in 2026, due to consumer trust and accessibility. Pharmacies give professional advice, which makes supplements more credible. Their established retail networks make sure that they are always available, which makes them the main way to buy DHA, even though online stores are becoming growing in popularity.
|
Aspect |
DHA in Diet |
DHA Supplements |
|
Source |
Fish (salmon, sardines), chia, flax |
Fish oil capsules, algal oil, purified liquids |
|
Daily Need |
~1,000 mg EPA+DHA (hard to achieve via diet) |
Convenient, standardized dosage |
|
Deficiency Risk |
>80% of Americans deficient |
Supplements bridge the gap |
|
New Innovations |
Limited to food intake |
Specialized supplements (e.g., ocular health, cancer prevention) |
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
To learn more about this report, Download Free Sample
North America is expected to dominate the DHA supplements market with 39% share in 2026, due to strong awareness about the health benefits of omega-3, they are commonly used in baby food, and the nutraceutical industry is well-established. A growing focus on cognitive health, cardiovascular health, and preventive care is also helping the region stay at the top of the market.
For instance, in March 2026, At Expo West 2026 in Anaheim, California, Aker BioMarine showcased its new krill oil products. The company focused on metabolic health, cognition, muscle strength, and better nutrient absorption for supplements with DHA-rich products like Superba Krill Oil and Lysoveta™. The theme was "Getting in Shape: Body & Mind."
Asia Pacific is expected to exhibit the fastest growth, because more people are becoming health-conscious, the middle class is growing, and governments are promoting good nutrition. China and India are driving growth by focusing on maternal and child health. Japan and South Korea are boosting demand for cognitive and cardiovascular health, which is supported by sustainable DHA sources from algae.
For instance, in January 2026, Aker BioMarine is growing in India ahead of Vitafoods India 2026 by forming strategic partnerships and coming up with new products. The company wants to make its mark in the nutraceutical market by working with G.C. Chemie Pharmie Ltd. to meet the growing demand for krill oil and algae-based DHA supplements.
In 2026, DHA supplements are extremely popular in the U.S. since individuals are aware about the benefits of omega-3s, they are widely used in baby food, and the nutraceutical industry is well-established. More and more people are focusing on cognitive health, heart health, and preventive care, which makes people of all ages more likely to use it.
For instance, in January 2026, In the United States, OCuSOFT released Retaine Omega Forté, a lemon-flavored liquid omega-3 supplement that helps with dry eyes. It gives 2,490 mg of EPA and DHA every day in the form of natural triglycerides, which are absorbed 70% better than ethyl ester oils. This improves eye health and makes it easier for patients to follow through with their treatment.
In 2026, there is a high demand for DHA supplements in China since individuals are becoming more interested in the health of mothers and children, the government is supporting nutrition programs, and people are learning more about the benefits for the heart and brain. Rapid urbanization and a preference for algae-based, sustainable DHA sources speed up adoption among people of all ages.
For instance, in November 2025, At the China International Import Expo in Shanghai, inne introduced iFocus DHA, a product aimed at school-aged children that provides precise nutrition to improve learning and thinking. The supplement was made to meet German pharmaceutical-grade standards and is part of a plan to expand globally. It focuses on family health with new DHA formulations based on breast milk and natural foods.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,943 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.0% | 2033 Value Projection: | USD 3,139 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
BASF Corporation, DSM, Cellana Inc., JC Biotech Pvt.Ltd, FEMICO, Croda International Plc, Pharma Marine AS, Clover Corporation, Omega Protein Corporation, Kingdomway Nutrition, Inc., ECPlaza Network Inc., Bizen Chemical Co.LTD, Stepan Company, Novotech Nutraceuticals, Inc., Arjuna Natural, Jiangsu Auqi Marine Biotechnology Co., Ltd., and Aker BioMarine |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The global health and wellness trend has led to a big rise in the use of dietary supplements, because people are prioritizing preventive healthcare and balanced nutrition. People are using supplements to fill the gap of nutrients, boost their immune systems, and improve their overall health. This rise is caused by changes in lifestyle, an aging population, and growing awareness of chronic diseases prevention. Due to this, the DHA Supplements Market growth is driven by rising demand, as DHA is known for its unique benefits for brain, eye, and heart health.
A greater number of individuals are taking DHA supplements because science has shown that they maintaining cardiovascular health, supporting eye function, and boosting cognitive performance. As lifestyle-related diseases become more common, people are looking for natural ways to improve their long-term health. DHA is a popular choice in the supplement industry because it works for people of all ages, from babies to the elderly. This trend is directly causing higher contribution of DHA supplements. the DHA supplements market demand, as awareness campaigns and clinical studies keep showing the importance of DHA for human health.
Fish oil continues to lead the DHA supplements market because it has an abundance of omega-3s, but problems with overfishing and allergies are making people seek out other options. Algal oil is becoming a vegan and eco-friendly option that offers the same DHA benefits as fish oil without the downsides of fish oil. Krill oil, on the other hand, has more omega-3s and antioxidants that help the body absorb them better and support heart health. Companies that invest in DHA from algae are in a good position to meet the growing demand from health-conscious and vegan customers. The DHA Supplements Market forecast states that these sustainable sources will change the way the market works, leading to new ideas, more trust from customers, and long-term growth.
Share
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
